Statement disclosing no deviation and Variation from object of issue as on March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has filed a compliance statement confirming that there is NO deviation or variation in the utilization of IPO funds as of March 31, 2026. The company raised INR 578.30 Lakhs through its IPO (allotment date: July 30, 2024) and has utilized INR 528.30 Lakhs so far. The funds were allocated for three purposes: Expansion of Diagnostic Centres (INR 498.67 Lakhs allocated, INR 448.67 Lakhs utilized), General Corporate Purposes (INR 41.33 Lakhs fully utilized), and Issue Related Expenses (INR 38.30 Lakhs fully utilized). INR 50 Lakhs remains unutilized. The Audit Committee reviewed the utilization and had no comments or concerns.
Positive signal for shareholders - the company is deploying IPO funds as intended with no deviations, indicating proper governance and adherence to the stated objects of the issue.